Celcuity (CELC) Debt Ratio (2021 - 2025)
Celcuity (CELC) posted Debt Ratio of 0.27 for Q4 2025, up 3.13% on a QoQ basis from 0.26 in Q3 2025, and down 31.98% year-over-year from 0.4 in Q4 2024.
Celcuity (CELC) Debt Ratio (2021 - 2025) Analysis & Trends
Celcuity's Debt Ratio history runs 5 years deep, the most recent figure standing at 0.27 for Q4 2025.
- Quarterly Debt Ratio fell 31.98% year-over-year to 0.27 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 0.27 (down 31.98% YoY) and the FY2025 annual result came in at 0.27, down 31.98% from the prior year.
- Debt Ratio was 0.27 for Q4 2025 at Celcuity, up from 0.26 in the prior quarter.
- Across five years, Debt Ratio topped out at 0.54 in Q2 2025 and bottomed at 0.16 in Q3 2021.
- A 5-year average of 0.27 and a median of 0.23 in 2023 frame the typical range for Debt Ratio.
- Annual changes were most pronounced in 2022 — Debt Ratio plunged 37.59% — and 2025, when it soared 126.27%.
- Celcuity's Debt Ratio stood at 0.17 in 2021, then advanced by 16.95% to 0.2 in 2022, then retreated by 2.73% to 0.19 in 2023, then surged by 105.85% to 0.4 in 2024, then plunged by 31.98% to 0.27 in 2025.
- Business Quant data shows CELC's Debt Ratio at 0.27 in Q4 2025, 0.26 in Q3 2025, and 0.54 in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | 1.41 |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 0.11 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 0.05 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Celcuity | 3.89 Bn | 3.89 Bn | - | 0.27 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.27 |
| Sep 30, 2025 | 0.26 |
| Jun 30, 2025 | 0.54 |
| Mar 31, 2025 | 0.45 |
| Dec 31, 2024 | 0.40 |
| Sep 30, 2024 | 0.35 |
| Jun 30, 2024 | 0.33 |
| Mar 31, 2024 | 0.20 |
| Dec 31, 2023 | 0.19 |
| Sep 30, 2023 | 0.26 |
| Jun 30, 2023 | 0.23 |
| Mar 31, 2023 | 0.22 |
| Dec 31, 2022 | 0.20 |
| Sep 30, 2022 | 0.23 |
| Jun 30, 2022 | 0.21 |
| Mar 31, 2022 | 0.19 |
| Dec 31, 2021 | 0.17 |
| Sep 30, 2021 | 0.16 |
| Jun 30, 2021 | 0.33 |